The suit says the program takes drugmakers’ property without compensation.
A pharmaceutical industry group is suing the state of Minnesota over its new insulin affordability program, which takes effect Wednesday.
Pharmaceutical Research and Manufacturers of America, or PhRMA, says the program the Legislature passed in April is unconstitutional and that drugmakers already offer alternatives to help people with diabetes. They are seeking a permanent injunction barring the state from enforcing the insulin act.
The lawmakers and advocates who fought for the measure argued that the existing programs drug companies provide are insufficient. After a protracted political battle at the State Capitol, they reached a deal legislators said would ensure people struggling with the skyrocketing price of the critical drug have a low-cost resource to secure it. Continue reading.